An innovation-driven international biopharmaceutical company
Investors 2
| Date | Name | Website |
| - | Qiming Ven... | qimingvent... |
| - | Qiming Ven... | qimingvc.c... |
Mentions in press and media 12
| Date | Title | Description |
| 30.12.2021 | Genor Biopharma : included on the "2021 New Economy Most Valuable Listed Company" list by CaiLian Press | 30 Dec, 2021 Genor Biopharma included on the "2021 New Economy Most Valuable Listed Company" list by CaiLian Press With the theme of "Gathering Momentum and Making a New Start", the CaiLian Press Investment Summit of 202... |
| 28.12.2021 | Genor Biopharma : announces the appointment of several world-renowned experts to its Scientific Advisory Board | 28 Dec, 2021 Genor Biopharma announces the appointment of several world-renowned experts to its Scientific Advisory Board Shanghai, China, December 28, 2021 - Genor Biopharma (Stock code: 6998.HK) today announced the appointment of several ... |
| 22.12.2021 | Genor Biopharma : announces submission of clinical trial application for EGFR/cMET/cMET trispecific antibody (GB263T) in Australia | 22 Dec, 2021 Genor Biopharma announces submission of clinical trial application for EGFR/cMET/cMETtrispecific antibody (GB263T) in Australia Shanghai, China, December 22, 2021 - Genor Biopharma (Stock code: 6998.HK) announced today that the... |
| 26.11.2021 | Genor Biopharma : Receives "Pudong New Area Intellectual Property Management Ability Building Award" | 26 Nov, 2021 Genor BiopharmaReceives "Pudong New Area Intellectual Property Management Ability Building Award" Recently, the Shanghai Pudong New Area Intellectual Property Office issued the "Announcement of Special Funds for ... |
| 24.11.2021 | Genor Biopharma : Named Outstanding Employer of the Year 2021 by Liepin | 24 Nov, 2021 Genor Biopharma Named Outstanding Employer of the Year 2021 by Liepin On November 23, 2021, Genor Biopharma received the Outstanding Employer of the Year 2021 award from Liepin. Liepin's Outstanding Employer of the Year 2021 aw... |
| 15.11.2021 | Genor Biopharma : Dr. HAN Shuhua and Mr. CHEN Wende from Genor Biopharma attended HNHE China 2021 | 15 Nov, 2021 Dr. HAN Shuhua and Mr. CHEN Wende from Genor Biopharma attended HNHE China 2021 HNHE China 2021 was held in Hainan province from November 12-14. Dr. HAN Shuhua, Chief Scientific Officer, and Mr. CHEN Wende, Chief Operating Offi... |
| 22.09.2021 | Genor Biopharma : Announces Clinical Data on Geptanolimab at ESMO 2021 | 20 Sep, 2021 Genor Announces Clinical Data on Geptanolimab at ESMO2021 September 20，2021，SHANGHAI，China - Genor Biopharma (Stock code: 6998.HK) today presented the latest clinical data on Geptanolimab (GB226) at ESMO (European Society for M... |
| 10.09.2021 | JHBP CY : Genor Announces GB226 Clinical Data to Be Presented at ESMO 2021 | 10 Sep, 2021 Genor Announces GB226 Clinical Data to Be Presented at ESMO2021 Genor Biopharma (Stock code: 6998.HK) announced today that the latest clinical data on Geptanolimab (GB226) would be presented at ESMO (European Society for Medica... |
| 25.03.2021 | Genor Biopharma Releases Its Annual Results for 2020 | Significant progresses in IND, clinical development, NDA/BLA, commercialization, BD and financing NDA/BLA progress – GB226 (Geptanolimab) Priority Review for PTCL, GB242 (infliximab (Remicade) biosimilar) under Review Clinical development –... |
| 01.06.2020 | Hillhouse leads $160m Series B funding in Chinese biopharma firm Genor | Premium Chinese clinical-stage biopharmaceutical firm Genor Biopharma on Monday announced that it has garnered $160 million in a Series B round of financing led by Asia-focused private equity major Hillhouse Capital Group. Continue reading ... |
Show more